Antiphospholipid antibody syndrome: recent findings on managing this challenging condition.
Patients with antiphospholipid syndrome can suffer recurrent thrombosis that is very difficult to manage. Recent research has demonstrated that high-intensity anticoagulation is not superior to standard therapy. Basic questions about the nature and treatment of this syndrome remain unanswered.
Crowther
Mark A
MA
Division of Hematology, McMaster University, St Joseph's Hospital, Hamilton, Ontario, Canada.
D000328:Adult; D000925:Anticoagulants / Q000627:therapeutic use; D016736:Antiphospholipid Syndrome / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008875:Middle Aged; D012307:Risk Factors; D055502:Secondary Prevention; D013927:Thrombosis / Q000209:etiology / Q000517:prevention & control*; D014859:Warfarin / Q000627:therapeutic use*
D000925:Anticoagulants; D014859:Warfarin